Article
Advances in pharmacogenetics and pharmacogenomics.
Journal of clinical pharmacology - 1 Sept 2000
Vesell E S
Abstract excerpt
Large differences among normal human subjects in the efficacy and safety of many therapeutic agents are caused by genetically controlled polymorphisms of drug-metabolizing enzymes, drug transporters, and drug receptors. Development of pharmacogenomics as a new field has accelerated progress in pharmacogenetics by elucidating at the level of the human genome the inherited basis for those large interindividual...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
